Cargando…

The effect of desacetyluvaricin on the expression of TLR4 and P53 protein in Hepg 2.2.15

BACKGROUND: Previous studies suggest that annonaceous may cause permeability glycoprotein (P-gp) function to abate, leading to cell apoptosis. It has also been reported that annonaceous acetogenins affect hepatocellular carcinoma (HCC) cells in the G1 phase, leading to apoptosis. Desacetyluvaricin (...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Hai Bin, Wu, Xian Lin, Yu, Bin, Liu, Kang Li, Zhou, Guang Xiong, Qian, Guo Qiang, Ju, Da Hong, Chen, Xiao Yin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212772/ https://www.ncbi.nlm.nih.gov/pubmed/22087162

Ejemplares similares

The suppression effects of desacetyluvaricin on hepatocellular carcinoma and its possible mechanism
por: Yu, Jian Zhong, et al.
Publicado: (2012)

HBV Integration-mediated Cell Apoptosis in HepG2.2.15
por: Hu, Xiaoge, et al.
Publicado: (2019)

Dihydroartemisinin inhibits HepG2.2.15 proliferation by inducing cellular senescence and autophagy
por: Zou, Jiang, et al.
Publicado: (2019)

Anti-Hepatitis B Virus Activity of Chickweed [Stellaria media (L.) Vill.] Extracts in HepG2.2.15 Cells
por: Ma, Lihua, et al.
Publicado: (2012)

An earthworm protease cleaving serum fibronectin and decreasing HBeAg in HepG2.2.15 cells
por: Wang, Xue-Qing, et al.
Publicado: (2008)

Two fragments of HBV DNA integrated into chrX: 11009033 and its genetic regulation in HepG2.2.15
por: Ruan, Peng, et al.
Publicado: (2023)

MicroRNA-520a suppresses HBV replication in HepG2.2.15 cells by inactivating AKT
por: Sun, Wei, et al.
Publicado: (2018)

TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK–STAT signaling pathway
por: Zhu, X, et al.
Publicado: (2016)

Effect of modified Xiaochaihu decoction-containing serum on HepG2.2.15 cells via the JAK2/STAT3 signaling pathway
por: Chen, Shaofang, et al.
Publicado: (2017)

IFN-CSP Inhibiting Hepatitis B Virus in HepG2.2.15 Cells Involves JAK-STAT Signal Pathway
por: Lu, Xuemei, et al.
Publicado: (2015)

Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line
por: Yuan, Sen, et al.
Publicado: (2021)

Hepatitis B virus induces G1 phase arrest by regulating cell cycle genes in HepG2.2.15 cells
por: Wang, Tianzhen, et al.
Publicado: (2011)

Trametenolic Acid B Triggers HSP90AA4P and Autophagy in HepG2/2.2.15 Cells by Proteomic Analysis
por: Shi, Feifan, et al.
Publicado: (2020)

Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling
por: Li, Lin, et al.
Publicado: (2016)

Identification of targets of JS-K against HBV-positive human hepatocellular carcinoma HepG2.2.15 cells with iTRAQ proteomics
por: Liu, Zhengyun, et al.
Publicado: (2021)

TDV-2215
Publicado: (1980)

Effects of 1,2,4,6-tetra-O-galloyl-β-D-glucose from P. emblica on HBsAg and HBeAg secretion in HepG2.2.15 cell culture
por: Xiang, Yang-fei, et al.
Publicado: (2010)

Correction: Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling
por: Li, Lin, et al.
Publicado: (2016)

ADAR1 Inhibits HBV DNA Replication via Regulating miR-122-5p in Palmitic Acid Treated HepG2.2.15 Cells
por: Yang, Hongli, et al.
Publicado: (2022)

Genome-Wide Transcriptome Analysis of CD36 Overexpression in HepG2.2.15 Cells to Explore Its Regulatory Role in Metabolism and the Hepatitis B Virus Life Cycle
por: Huang, Jian, et al.
Publicado: (2016)

Antiproliferative effect of urolithin A, the ellagic acid-derived colonic metabolite, on hepatocellular carcinoma HepG2.2.15 cells by targeting Lin28a/let-7a axis
por: Qiu, Zhenpeng, et al.
Publicado: (2018)

2215: Neuropilin-2 is expressed by activated alveolar macrophages and negatively regulates allergic airway inflammation
por: Moran, Timothy P., et al.
Publicado: (2018)

2215 The value of storytelling in community stakeholder feedback for clinical and translational research
por: Novak, Laurie L., et al.
Publicado: (2018)

Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells
por: Wu, Shixing, et al.
Publicado: (2013)

Cadmium Impairs p53 Activity in HepG2 Cells
por: Urani, C., et al.
Publicado: (2014)

Effects of TLR4 gene silencing on the proliferation and apotosis of hepatocarcinoma HEPG2 cells
por: LIU, YATING, et al.
Publicado: (2016)

PReS-FINAL-2215: Genotype-phenotype correlations in children with Familial Mediterranean Fever in Germany
por: Gohar, F, et al.
Publicado: (2013)

PB2215: GLOBAL EPIDEMIOLOGY OF SICKLE CELL DISEASE: A SYSTEMATIC LITERATURE REVIEW
por: Colombatti, R., et al.
Publicado: (2022)

Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells
por: LIU, BIN, et al.
Publicado: (2016)

2215. Diarrheal Illness as a Risk Factor for Subsequent Respiratory Infection Among Women and Infants in Nepal
por: Newman, Kira L, et al.
Publicado: (2019)

Small protein Cgl2215 enhances phenolic tolerance by promoting MytA activity in Corynebacterium glutamicum
por: Gu, Huawei, et al.
Publicado: (2022)

TLR3 Activation of Hepatic Stellate Cell Line Suppresses HBV Replication in HepG2 Cells
por: Zhang, Biao, et al.
Publicado: (2018)

Correction to Lancet Psychiatry 2021; published online Feb 19. https://doi.org/10.1016/S2215-0366(21)00043-2
Publicado: (2021)

Correction to Lancet Psychiatry 2021; published online April 13. https://doi.org/10.1016/S2215-0366(21)00091-2
Publicado: (2021)

Eurycomanone induce apoptosis in HepG2 cells via up-regulation of p53
por: Zakaria, Yusmazura, et al.
Publicado: (2009)

The Effect of Encapsulated Apigenin Nanoparticles on HePG-2 Cells through Regulation of P53
por: Mabrouk Zayed, Mayada Mohamed, et al.
Publicado: (2022)

Diosmetin triggers cell apoptosis by activation of the p53/Bcl-2 pathway and inactivation of the Notch3/NF-κB pathway in HepG2 cells
por: Qiao, Jie, et al.
Publicado: (2016)

Konjac glucomannan reverses multi-drug resistance of HepG2/5-FU cells by suppressing AKT signaling and increasing p53 expression
por: Chen, Bin, et al.
Publicado: (2020)

PB2215: HYDROXYUREA-INDUCED CUTANEUS ADVERSE EVENTS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA: A SINGLE-CENTER EXPERIENCE
por: Peña, Amaia Lopez, et al.
Publicado: (2023)

PP4R1 accelerates cell growth and proliferation in HepG2 hepatocellular carcinoma
por: Wu, Gang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7gg8f5mbkhv1i9j6mq431qa9f4